Talphera, Inc. Files 8-K for Material Agreement
Ticker: TLPH · Form: 8-K · Filed: Oct 1, 2024 · CIK: 1427925
| Field | Detail |
|---|---|
| Company | Talphera, Inc. (TLPH) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
Talphera (formerly AcelRx) signed a big deal on 9/30/24. Details in 8-K.
AI Summary
On September 30, 2024, Talphera, Inc. entered into a Material Definitive Agreement. The filing also includes financial statements and exhibits related to this agreement. Talphera, Inc. was formerly known as AcelRx Pharmaceuticals Inc. until February 22, 2008.
Why It Matters
This 8-K filing indicates a significant new agreement for Talphera, Inc., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which suggests significant business developments that could carry inherent risks.
Key Players & Entities
- TALPHERA, INC. (company) — Registrant
- ACELRX PHARMACEUTICALS INC (company) — Former company name
- September 30, 2024 (date) — Date of earliest event reported
- 001-35068 (other) — SEC File Number
- 1850 Gateway Drive, Suite 175 San Mateo, CA 94404 (address) — Principal executive offices
FAQ
What is the nature of the Material Definitive Agreement entered into by Talphera, Inc. on September 30, 2024?
The filing does not specify the details of the Material Definitive Agreement, only that one was entered into on September 30, 2024.
What was Talphera, Inc.'s former name and when did the name change occur?
Talphera, Inc.'s former name was AcelRx Pharmaceuticals Inc., and the date of the name change was February 22, 2008.
What is the principal executive office address for Talphera, Inc.?
The principal executive office address for Talphera, Inc. is 1850 Gateway Drive, Suite 175, San Mateo, CA 94404.
What is the SEC File Number for Talphera, Inc.?
The SEC File Number for Talphera, Inc. is 001-35068.
What is the SIC code for Talphera, Inc.?
The Standard Industrial Classification (SIC) code for Talphera, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 551 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-10-01 17:29:07
Key Financial Figures
- $0.001 — ge on which registered Common Stock , $0.001 par value TLPH The Nasdaq Global Mar
Filing Documents
- acrx20241001_8k.htm (8-K) — 23KB
- ex_728872.htm (EX-10.1) — 21KB
- 0001437749-24-030380.txt ( ) — 177KB
- tlph-20240930.xsd (EX-101.SCH) — 3KB
- tlph-20240930_def.xml (EX-101.DEF) — 11KB
- tlph-20240930_lab.xml (EX-101.LAB) — 15KB
- tlph-20240930_pre.xml (EX-101.PRE) — 11KB
- acrx20241001_8k_htm.xml (XML) — 3KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On September 30, 2024, Talphera, Inc. (the "Company"), amended its securities purchase agreements, dated January 17, 2024, with entities affiliated with Nantahala Management, LLC (the "Agreements"), to extend to June 30, 2025 the date by which the Company must achieve the precedent conditions to the second closing thereunder (the "Amendments"). If prior to the second closing, the Company consummates an equity financing, then the purchasers shall be released from their obligation to purchase additional shares of common stock and/or pre-funded warrants pursuant to the Agreements. The foregoing description of the Amendments is a summary and is qualified in its entirety by reference to the provisions thereof, a copy of which is attached to this Current Report as Exhibit 10.1, which is incorporated by reference herein. The form of the Agreements is filed as Exhibit 10.1 to the Company's Current Report on Form 8-K (file no. 001-35068) filed with the Securities and Exchange Commission on January 22, 2024.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Form of Amendment No. 1 to Securities Purchase Agreement, dated September 30, 2024, by and among Talphera, Inc. and entities affiliated with Nantahala Management, LLC. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 1, 2024 TALPHERA, INC. By: /s/ Raffi Asadorian Raffi Asadorian Chief Financial Officer